Clinical evidence and use of extrapolation in European biosimilar marketing authorizations

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Clinical evidence and use of extrapolation in European biosimilar marketing authorizations. / Druedahl, Louise C.; Vive Nielsen, Camilla; Hallgreen, Christine Erikstrup.

In: BioDrugs, 2023.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Druedahl, LC, Vive Nielsen, C & Hallgreen, CE 2023, 'Clinical evidence and use of extrapolation in European biosimilar marketing authorizations', BioDrugs.

APA

Druedahl, L. C., Vive Nielsen, C., & Hallgreen, C. E. (2023). Clinical evidence and use of extrapolation in European biosimilar marketing authorizations. Manuscript in preparation.

Vancouver

Druedahl LC, Vive Nielsen C, Hallgreen CE. Clinical evidence and use of extrapolation in European biosimilar marketing authorizations. BioDrugs. 2023.

Author

Druedahl, Louise C. ; Vive Nielsen, Camilla ; Hallgreen, Christine Erikstrup. / Clinical evidence and use of extrapolation in European biosimilar marketing authorizations. In: BioDrugs. 2023.

Bibtex

@article{4870e0cf55394bb3ba5fe8238032b17c,
title = "Clinical evidence and use of extrapolation in European biosimilar marketing authorizations",
author = "Druedahl, {Louise C.} and {Vive Nielsen}, Camilla and Hallgreen, {Christine Erikstrup}",
year = "2023",
language = "English",
journal = "BioDrugs",
issn = "1173-8804",
publisher = "Adis International Ltd",

}

RIS

TY - JOUR

T1 - Clinical evidence and use of extrapolation in European biosimilar marketing authorizations

AU - Druedahl, Louise C.

AU - Vive Nielsen, Camilla

AU - Hallgreen, Christine Erikstrup

PY - 2023

Y1 - 2023

M3 - Journal article

JO - BioDrugs

JF - BioDrugs

SN - 1173-8804

ER -

ID: 329423939